Skip to main content
OLYMPUS CORPORATION logo

OLYMPUS CORPORATION — Investor Relations & Filings

Listed IPO Jan 2000
Ticker · 7733 ISIN · JP3201200007 LEI · 5299000Y52IFDI1I2A21 T Manufacturing
Open in API
Filings indexed 165 across all filing types
Latest filing 2025-11-07 Regulatory Filings
Country JP Japan
Listing T 7733 · 6 venues

About OLYMPUS CORPORATION

https://www.olympus-global.com/

Olympus Corporation is a global medical technology (medtech) company focused on making people's lives healthier, safer, and more fulfilling. The company develops, manufactures, and commercializes innovative solutions for the medical and healthcare sectors, specializing in early detection, diagnosis, and minimally invasive treatment. Its core product portfolio includes medical endoscopes, endotherapy devices, and therapeutic energy devices. These technologies are applied across various medical specialties such as gastroenterology, urology, gynecology, and general surgery. Leveraging its expertise in optical and digital precision technology, Olympus provides comprehensive solutions that also encompass advanced video imaging systems and system integration services for healthcare facilities.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the contents of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 2026
2025-11-07 Japanese
半期報告書－第158期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Olympus Corporation under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, management analysis (MD&A), and business performance data for the interim period ending September 30, 2025. As it is a formal, substantive financial report for an interim period, it falls under the 'Interim / Quarterly Report' category. H1 2026
2025-11-07 Japanese
Q2 2026
Call Transcript
2025-11-07 English
2026年３月期 第２四半期（中間期）決算短信〔ＩＦＲＳ〕（連結）
Regulatory Filings
2025-11-07 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a '自己株券買付状況報告書' (Report on Status of Acquisition of Treasury Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the specific monthly acquisition and disposal of the company's own shares (share buybacks). According to the provided filing definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (Code: POS).
2025-10-07 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on the Status of Repurchase of Own Shares' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the specific daily transactions of share buybacks conducted by Olympus Corporation during the month of August 2025. This document type directly corresponds to the 'Transaction in Own Shares' (POS) category, as it reports the company's activity in buying back its own shares.
2025-09-05 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.